Getinge AB (publ) (0GZV.IL)
| Previous close | 231.45 |
| Open | 232.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 229.40 - 232.40 |
| 52-week range | 174.50 - 268.80 |
| Volume | |
| Avg. volume | 391,306 |
| Market cap | 63.276B |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | 29.07 |
| EPS (TTM) | 7.92 |
| Earnings date | 18 July 2024 |
| Forward dividend & yield | 4.25 (2.23%) |
| Ex-dividend date | 27 Apr 2023 |
| 1y target est | N/A |
GuruFocus.comGetinge AB's Dividend Analysis
Getinge AB (GNGBY) recently announced a dividend of $0.42 per share, payable on 2024-05-14, with the ex-dividend date set for 2024-04-23. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Getinge AB's dividend performance and assess its sustainability.
- Reuters
UPDATE 2-Rising bond yields, Middle East conflict weigh on European stocks
European shares edged lower on Monday as rising government bond yields and concerns over the Israel-Hamas war kept investors on edge, while Italy's FTSE MIB index was among top gainers across the regional markets. The pan-European STOXX 600 ended 0.1% lower after declines of over 3% in the previous week. While European Union leaders are set to call for a "humanitarian pause" in the Israel-Hamas war so aid could reach them, Israel continued its bombardment of the besieged enclave.
- PR Newswire
Getinge acquires Healthmark Industries Co. Inc.
Getinge announced today that it has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a leading provider of innovative instrument care and infection control consumables, for approximately USD 320 M. This strategic step enhances Getinge's presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark.
